Company Filing History:
Years Active: 1989
Title: Innovations by Lan-Qin Bai
Introduction
Lan-Qin Bai is a notable inventor based in Upton, NY, who has made significant contributions to the field of radioligands. With a focus on developing innovative solutions for medical imaging, Bai's work has implications for both research and clinical applications.
Latest Patents
Bai holds a patent for "No-carrier-added [.sup.18 F]-N-fluoroalkylspiroperidols." This patent discloses radioligands labeled with the positron-emitting radionuclide [.sup.18 F], which are suitable for dynamic studies in living humans using positron emission transaxial tomography. The new [.sup.18 F]-N-fluoroalkylspiroperidols, characterized by an alkyl group containing 2-6 carbon atoms, exhibit an extremely high affinity for dopamine receptors. This results in enhanced uptake and retention in the brain while reducing radiation burden. These features make the radioligands valuable for mapping dopamine receptors in both normal and disease states in the living brain. Additionally, Bai's patent includes a new synthetic procedure for these radioligands and a method for preparing the radiolabeled alkyl halide alkylating reagents.
Career Highlights
Bai's career is marked by a commitment to advancing medical imaging technologies. His innovative approach has led to the development of radioligands that improve the accuracy of brain imaging, which is crucial for diagnosing and understanding various neurological conditions.
Collaborations
Bai has collaborated with notable colleagues, including Chyng-Yann Shiue and Alfred P Wolf, to further enhance the research and development of radioligands. These collaborations have contributed to the successful advancement of their shared goals in the field of medical imaging.
Conclusion
Lan-Qin Bai's contributions to the field of radioligands represent a significant advancement in medical imaging technology. His innovative work continues to pave the way for improved diagnostic tools in neuroscience.